News & Updates

Nicorandil improves PCI outcomes in STEMI patients
Nicorandil improves PCI outcomes in STEMI patients
14 Sep 2022

In patients with ST‐segment–elevation myocardial infarction (STEMI), treatment with nicorandil prior to undergoing primary percutaneous coronary intervention (PCI) may result in improved myocardial perfusion grade, increased left ventricular ejection fraction, and reduced myocardial infarct size, according to data from the CHANGE* study.

Nicorandil improves PCI outcomes in STEMI patients
14 Sep 2022